Cargando…
Targeting EGF-receptor-signalling in squamous cell carcinomas of the head and neck
Despite significant advances in the use of surgery, chemotherapy and radiotherapy to treat squamous cell carcinoma of the head and neck (SCCHN), prognosis has improved little over the past 30 years. There is a clear need for novel, more effective therapies to prevent relapse, control metastases and...
| Autores principales: | , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2007
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360023/ https://www.ncbi.nlm.nih.gov/pubmed/17224925 http://dx.doi.org/10.1038/sj.bjc.6603566 |